GeoPolitics Pulse

The Heartbeat of World events

InflaRx Receives European Commission Approval for GOHIBIC® – GlobeNewswire

by ·

InflaRx Receives European Commission Approval for GOHIBIC® (vilobelimab) for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome ( …Read More

Related posts:

  1. InflaRx Receives European Commission Approval for GOHIBIC® (vilobelimab) for the … – BioSpace
  2. European Commission (EC) Extends the Approval of Evkeeza® – GlobeNewswire
  3. Calliditas partner STADA receives European Commission decision for full approval of … – KXAN
  4. TEPKINLY® (epcoritamab) Receives Second European Commission Approval for … – Business Wire
  5. AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab …